Production of HPV vaccine to start in 2023: Adar Poonawala
21 Oct 2022
The Serum Institute of India will start the production of India's first indigenously developed quadrivalent Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical cancer in the first quarter of 2023. Due to the COVID-19 pandemic, the production of vaccines got delayed. "The capacity got delayed by one year...
Read More